本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance principles for healthcare This collaborative dialogue explored key challenges and opportunities in unlocking AI's potential, and the optimal governance principles required to develop an agile framework for effectively integrating AI in healthcare Its key principles are rooted in inclusion, equity, and ethics, to ensure patient safety while enabling responsible innovation Participants included academics, technology experts, and pharmaceuticals leaders from across Africa, the US, Europe, Asia, and the Middle East ABU DHABI, UAE, April 24, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, convened senior international government officials at the Health Leaders Roundtable to shape a Declaration on AI governance principles for healthcare. Held on the sidelines of Abu Dhabi Global Health Week (ADGHW), it considered the challenges and opportunities in unlocking the potential of artificial intelligence (AI), and explored key principles in the governance of AI in healthcare. Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable Hosted together with PwC Middle East, findings from the roundtable will inform the development of a collaborative approach that will serve as a reference for governments, health systems, and innovators to ensure that AI's integration into healthcare systems is transparent, responsible, and inclusive. His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, added: "AI is not tomorrow's technology, it is today's reality. While many of us are adapting to its rise, our children will grow up with it as the norm. That's why the decisions we make today, around ethics, equity, and safety, must be made together. Through this declaration, we will establish a globally accessible guideline that extends beyond borders and commercial interests. This document is a call to action for governments, innovators, and healthcare leaders everywhere." The forthcoming Declaration on governance principles for AI in healthcare will outline guiding principles for responsible AI deployment to improve health outcomes and protect patient rights. Designed as a globally accessible resource, the declaration will inspire unified governance and serve as a trusted reference for stakeholders worldwide. In her opening remarks at the Roundtable, Her Excellency Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: "AI has extraordinary potential in healthcare. It is already transforming how we deliver care, how we diagnose, and how we discover. But with great power comes great responsibility. In Abu Dhabi, we are harnessing AI as our engine and policy as our platform, turning data into life-saving insight, and insight into meaningful action. Our vision is to deliver healthcare that is precise, proactive, and personal and to do so in a way that puts people, not technology, at the centre." During the Roundtable, participants emphasised the need for agile legal and regulatory frameworks to enable the safe and ethical application of AI in healthcare, while enabling innovation. With an emphasis on the need for a human-centred approach, discussions explored key themes including standardisation of data, data privacy and trust, skills development and community engagement. Key insights from the Roundtable highlight the need for: Transparent testing frameworks to ensure AI tools meet real-world clinical standards; Collaborative ecosystems that unite regulators, industry, academia, and civil society across geographies; Responsible data access that protects privacy, ensure security, and clarify ownership; Addressing the AI skills gap by scaling education and awareness across healthcare systems and prepare healthcare workforces for a new era. Aligning AI use cases with real-world patient and system challenges, avoiding technology for technology's sake. The Health Leaders Roundtable brought together a distinguished group of local and international voices, including government officials, AI experts, healthcare executives, and multilateral organisations, to explore the shared principles and practices needed to deploy AI responsibly, effectively, and equitably. These themes build on Abu Dhabi's rapidly advancing AI ecosystem, which in the field of health, is taking billions of data points, and turning them into life-changing insights. Supporting the Emirates's approach is the Global AI Healthcare Academy, launched by DoH, which equips healthcare professionals worldwide with theoretical knowledge and hands-on training needed to implement AI technologies effectively, setting a global standard for capacity building. In addition, Malaffi - the region's first Health Information Exchange - provides secure, real-time access to patient data across both public and private healthcare providers. This seamless data integration is crucial for enabling AI tools to be deployed safely, efficiently, and at scale. ADGHW is a major government initiative from DoH, and serves as a platform for innovation and collaboration under the 2025 theme 'Towards Longevity: Redefining Health and Well-being.' By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being. For media inquiries or interview opportunities, please contact: Maroun Farah, Senior Media Relations Manager, Weber ShandwickE: mfarah@webershandwick.com T: +971 55 166 2557
Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance principles for healthcare This collaborative dialogue explored key challenges and opportunities in unlocking AI's potential, and the optimal governance principles required to develop an agile framework for effectively integrating AI in healthcare Its key principles are rooted in inclusion, equity, and ethics, to ensure patient safety while enabling responsible innovation Participants included academics, technology experts, and pharmaceuticals leaders from across Africa, the US, Europe, Asia, and the Middle East ABU DHABI, UAE, April 24, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, convened senior international government officials at the Health Leaders Roundtable to shape a Declaration on AI governance principles for healthcare. Held on the sidelines of Abu Dhabi Global Health Week (ADGHW), it considered the challenges and opportunities in unlocking the potential of artificial intelligence (AI), and explored key principles in the governance of AI in healthcare. Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable Hosted together with PwC Middle East, findings from the roundtable will inform the development of a collaborative approach that will serve as a reference for governments, health systems, and innovators to ensure that AI's integration into healthcare systems is transparent, responsible, and inclusive. His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, added: "AI is not tomorrow's technology, it is today's reality. While many of us are adapting to its rise, our children will grow up with it as the norm. That's why the decisions we make today, around ethics, equity, and safety, must be made together. Through this declaration, we will establish a globally accessible guideline that extends beyond borders and commercial interests. This document is a call to action for governments, innovators, and healthcare leaders everywhere." The forthcoming Declaration on governance principles for AI in healthcare will outline guiding principles for responsible AI deployment to improve health outcomes and protect patient rights. Designed as a globally accessible resource, the declaration will inspire unified governance and serve as a trusted reference for stakeholders worldwide. In her opening remarks at the Roundtable, Her Excellency Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, stated: "AI has extraordinary potential in healthcare. It is already transforming how we deliver care, how we diagnose, and how we discover. But with great power comes great responsibility. In Abu Dhabi, we are harnessing AI as our engine and policy as our platform, turning data into life-saving insight, and insight into meaningful action. Our vision is to deliver healthcare that is precise, proactive, and personal and to do so in a way that puts people, not technology, at the centre." During the Roundtable, participants emphasised the need for agile legal and regulatory frameworks to enable the safe and ethical application of AI in healthcare, while enabling innovation. With an emphasis on the need for a human-centred approach, discussions explored key themes including standardisation of data, data privacy and trust, skills development and community engagement. Key insights from the Roundtable highlight the need for: Transparent testing frameworks to ensure AI tools meet real-world clinical standards; Collaborative ecosystems that unite regulators, industry, academia, and civil society across geographies; Responsible data access that protects privacy, ensure security, and clarify ownership; Addressing the AI skills gap by scaling education and awareness across healthcare systems and prepare healthcare workforces for a new era. Aligning AI use cases with real-world patient and system challenges, avoiding technology for technology's sake. The Health Leaders Roundtable brought together a distinguished group of local and international voices, including government officials, AI experts, healthcare executives, and multilateral organisations, to explore the shared principles and practices needed to deploy AI responsibly, effectively, and equitably. These themes build on Abu Dhabi's rapidly advancing AI ecosystem, which in the field of health, is taking billions of data points, and turning them into life-changing insights. Supporting the Emirates's approach is the Global AI Healthcare Academy, launched by DoH, which equips healthcare professionals worldwide with theoretical knowledge and hands-on training needed to implement AI technologies effectively, setting a global standard for capacity building. In addition, Malaffi - the region's first Health Information Exchange - provides secure, real-time access to patient data across both public and private healthcare providers. This seamless data integration is crucial for enabling AI tools to be deployed safely, efficiently, and at scale. ADGHW is a major government initiative from DoH, and serves as a platform for innovation and collaboration under the 2025 theme 'Towards Longevity: Redefining Health and Well-being.' By convening diverse stakeholders from around the world, ADGHW is a community without borders that seeks to advance the future of health and well-being. For media inquiries or interview opportunities, please contact: Maroun Farah, Senior Media Relations Manager, Weber ShandwickE: mfarah@webershandwick.com T: +971 55 166 2557 Photo - https://mma.prnasia.com/media2/2672529/ADGHW.jpg?p=medium600Logo - https://mma.prnasia.com/media2/2666335/5285303/Abu_Dhabi_Global_Health_Week_Logo.jpg?p=medium600
GUANGZHOU, China, April 14, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, participated in the "AI Empowers Biopharma" exchange panel hosted by the Guangzhou Development District Talent Education Group on April 3, 2025, joining 28 enterprises to explore cutting-edge applications of AI healthcare. Guo Zhi, Senior Vice President of Technology of Fangzhou, shared during the panel: "At Fangzhou, we've systematically addressed the core challenges in healthcare delivery by pioneering our AI + H2H Smart Healthcare Ecosystem. This innovative model extends critical services — including chronic disease management, patient education, and medication delivery — directly into patients' homes, significantly improving care accessibility and timeliness while enhancing the overall treatment experience." Mitigate AI hallucinations The Company also unveiled its proprietary framework to mitigate AI hallucinations in medical applications, combining a self-developed training platform with a professional medical knowledge base and data sandbox. This approach powers Fangzhou's "AI Agent Matrix," featuring round-the-clock diagnostic support, intelligent customer service tools, and AI-assisted health content creation, collectively enhancing care accessibility while reducing operational costs. Blueprint for Vertical AI Leadership Moving forward, Fangzhou will intensify its focus on the vertical field of AI + Healthcare, leveraging its proven H2H Smart Healthcare Ecosystem to drive deeper integration of AI across online healthcare use cases. The Company will seize opportunities like this panel to strengthen collaboration with biopharmaceutical enterprises and research institutions, fostering synergistic development between regional biomedicine and smart healthcare. AI-Powered Growth Strategy Fangzhou's growth strategy centers on deploying cutting-edge AI technologies like DeepSeek-V3 while deepening partnerships with industry leaders such as Tencent Health and Tencent Cloud. These initiatives are designed to push the boundaries of AI-powered healthcare, strengthen the Company's technological leadership, and fast-track the market adoption of its innovations — all with the goal of delivering superior care experiences and enhanced solutions for patients and users. About Fangzhou Inc. Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit https://investors.jianke.com. About the "AI Empowers Biopharma" Exchange Panel Guangzhou Development District is accelerating its push to become a biopharma innovation leader, with this "AI Empowers Biopharma" exchange panel spotlighting AI-driven antibody research, quantum computing for drug development, and smart healthcare ecosystems. Media Contact For further inquiries or interviews, please reach out to:Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements
SHANGHAI, March 26, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced a strategic collaboration with Tencent Health and Tencent Cloud to accelerate AI-driven healthcare solutions by integrating the DeepSeek open-source AI Model on its platform. Following on the Company's local deployment of DeepSeek's open-source large language model in February, the partnership leverages Tencent Cloud's infrastructure to help power Fangzhou's upgraded "AI Agent 2.0" platform. The "AI Agent 2.0" leverages DeepSeek's analytical capabilities and Tencent's Hunyuan model to enhance the efficiency of pharmaceutical logistics and online healthcare services. Dr. Xie Fangmin, CEO of Fangzhou, emphasized the initiative's goal to "deliver smarter, more efficient solutions for millions of users." DeepSeek's Competitive Edge: Enabling Cost Efficiency and Data Privacy DeepSeek's rapid adoption stems from its high performance, cost efficiency, and robust security. Its Mixture-of-Experts (MoE) architecture ensures scalable efficiency, while private deployment ensures compliance with data privacy regulations since customer data is not transmitted to third parties. As a pioneer in Internet healthcare, Fangzhou's proprietary AI platform, designed for rapid local deployment of multiple large language models, quickly integrated DeepSeek's models. Support from Tencent Cloud's infrastructure has also allowed Fangzhou to enhance its platform's capabilities to better serve patients and healthcare providers. Deepening Collaboration: Fangzhou and Tencent Pioneer AI-Enabled Healthcare The deployment of "AI Agent 2.0" represents a milestone in Fangzhou's strategic partnership with Tencent Health and Tencent Cloud. The upgraded system focuses on two core scenarios: patient services and physician workflows, and developing novel functionality and data-driven enhancements. About Fangzhou Inc. Fangzhou Inc. (06086.HK) is China's leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit https://investors.jianke.com. About Tencent Tencent, a global leader in digital technology, is dedicated to enriching the lives of Internet users, and enhancing operational efficiency for its partners across the healthcare, insurance, and pharmaceutical sectors. About DeepSeek Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co., Ltd. ("DeepSeek") is a Chinese AI firm specializing in large language models (LLMs). Founded in July 2023 and backed by hedge fund High-Flyer, DeepSeek launched its flagship DeepSeek-R1 model and chatbot in January 2025. Media Contact For further inquiries or interviews, please reach out to:Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements
QINGDAO, China, Feb. 18, 2025 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) (hereinafter referred to as "Akso Health," "the Company," or "we") announced today its integration of DeepSeek's advanced artificial intelligence technology. This initiative aims to further enhance AI-powered medical consultation, optimize healthcare resource allocation, and provide users with more precise and efficient medical services. The utilization of DeepSeek not only represents a significant breakthrough in the field of AI-driven healthcare but also sets a new benchmark for the industry's intelligent transformation. As an innovative medical technology company, AHG leverages DeepSeek's multimodal large-scale models, deep learning frameworks, and big data processing capabilities to upgrade its AI-powered diagnosis system. The upgraded system will integrate patient text descriptions, medical imaging, and laboratory test results, utilizing NLP and deep learning to provide more accurate diagnoses and personalized treatment recommendations. Additionally, DeepSeek's model training framework helps AHG refine its AI models, enhancing diagnostic accuracy and response speed. Furthermore, AHG will utilize DeepSeek to develop an AI-powered medical assistant to support doctors in retrieving patient records, analyzing similar cases, and recommending treatment plans, aiming to significantly improve diagnostic efficiency. AHG also incorporates human-centric AI interactions, ensuring a more natural and empathetic user experience, reducing patient anxiety, and optimizing the overall consultation experience. Ms. Yilin (Linda) Wang , CEO of AHG stated, "The utilization of DeepSeek is a major milestone in AI powered healthcare. By leveraging DeepSeek's technological expertise, we aim to enhance diagnostic accuracy and deliver superior healthcare services to users worldwide." Looking ahead, AHG will continue to explore AI applications in research and development, health management, and telemedicine, driving the healthcare industry toward a smarter and more efficient future. About Akso Health Group Akso Health Group (NASDAQ: AHG), formerly known as Xiaobai Maimai Inc., upon exploration of e-commerce platforms, the Company started exploring the healthcare equipment and product trading and related healthcare services business. Currently we specialize in the sales of medical devices in China and in the United States and also conduct certain radiotherapy oncology centers in the U.S. From March 2024, the Company indirectly acquired the equity interests of Tianjin Deyihui Internet Hospital Co., Ltd and Tianjin Deyihui Clinic Co., Ltd. which provides online medical consultations for initial diagnosis, follow-up consultations, and management of chronic diseases. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "potential," "continue," "ongoing," "targets," "guidance" and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements that involve factors, risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors and risks include, but not limited to the following: risks related to our ability to obtain equipment, technology, license and talents at satisfactory terms to grow the medical equipment business and/or to start the planned healthcare business, if at all; risks regarding the effect of the COVID-19 pandemic on the Company and the Company's position in a post-COVID-19 environment; risks related to the Company's ability to adapt and make the necessary adjustments to compete and operate effectively; risks related to decisions or changes in governmental policies in the healthcare segment; risks related to increased competition and the development of new competing services; the risk that we may be unable to develop or achieve commercial success for our medical and healthcare services in a timely manner, or at all; risks related to regulatory requirements or enforcement in relevant jurisdiction and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to successfully integrate and derive benefits from any technologies that we license or acquire; risks related to our projections about our business, results of operations and financial condition; and risks related to the potential market opportunity for our products and services. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the SEC. All information provided in this announcement is current as of the date of this announcement, and the Company does not undertake any obligation to update such information, except as required under applicable law. For more information, please visit http://www.ahgtop.com/en/index.html For investor inquiries, please contact: Akso Health GroupInvestor RelationsEmail: ir@ahgtop.com
DAVOS, Switzerland, Jan. 24, 2025 /PRNewswire/ -- From January 20 to 24, the World Economic Forum Annual Meeting 2025, also known as Winter Davos, gathered global leaders in Davos, Switzerland. Representing China's AI-powered healthcare sector, Ms. Gong Rujing(Yingying), Founder and Chairwoman of Yidu Tech and a distinguished Young Global Leader, actively participated in high-profile discussions, exchanging insights with leaders across government, business, and academia. She shared Yidu Tech's groundbreaking practices and innovative solutions while addressing key challenges and opportunities in scaling digital health and fostering leadership resilience in uncertain times. Ms. Gong Rujing (Yingying) Speaks at Davos The Future of Digital Health: Opportunities and Challenges On January 23, Ms. Gong participated in a panel discussion on scaling digital health solutions globally, alongside Italy's Minister of Health Orazio Schillaci, H.E. Mansoor Al-Mansoori, Chairman of Abu Dhabi's Department of Health, and Peter Sands, Executive Director of the Global Fund. Moderated by John Halamka, President of Mayo Clinic Platform, the discussion delved into practical strategies for advancing digital health systems, emphasizing the importance of trust, data standardization, and security. Ms. Gong highlighted Yidu Tech's role as a trailblazer in AI-powered healthcare innovation, having supported over 240 high-impact scientific publications, improved clinical trial efficiency by 40%, and served 34 million policyholders with tailored health insurance solutions. She emphasized that digital health is transforming healthcare ecosystems by enabling personalized care, smarter decision-making, and more sustainable healthcare systems. Expanding Global Footprint Yidu Tech has actively expanded into key international markets such as Southeast Asia and the United States, with plans to further enhance its presence in Japan, Europe, and other regions. Through its agile globalization strategy, Yidu Tech has demonstrated its ability to adapt to diverse regulatory and cultural landscapes while building strong partnerships. "Operating in China's competitive market has forged a team with unparalleled resilience and adaptability," Ms. Gong remarked. "This foundation enables us to bring innovative AI-powered healthcare solutions to more regions, addressing global healthcare challenges with local relevance." Leadership Resilience in a Complex World On January 24, Ms. Gong joined Wikipedia Founder Jimmy Wales and former Ecuadorian Vice President Otto Sonnenholzner in a discussion on leadership resilience in complex and rapidly changing environments. Drawing from Yidu Tech's experiences, she shared how the company leveraged AI-powered tools to support epidemic prevention, optimize resource allocation, and accelerate the approval of life-saving treatments during the pandemic. Ms. Gong also discussed Yidu Tech's deployment of decentralized clinical trial (DCT) solutions, which significantly reduce costs and time for new drug development. Notably, the company supported the approval of China's first 3CL-targeted COVID-19 antiviral, demonstrating its ability to drive innovation in critical healthcare areas. Transforming Healthcare with AI-Powered Solutions Since its founding, Yidu Tech has remained committed to tackling key healthcare challenges by delivering impactful solutions: Population Health Management: Launched initiatives that support regional health systems and improve population well-being in cities like Beijing and Ningbo. Provider Solutions: Empowered hospitals and healthcare organizations to improve operational efficiency and deliver better patient care. Advancing Clinical Research: Facilitated scientific breakthroughs and improved the efficiency of drug development. Insurance Innovation: Designed innovative products for high-risk populations, serving over 34 million policyholders through Huiminbao programs in China. Through these initiatives, Yidu Tech has strengthened its position as a global leader in AI-powered healthcare, fostering innovation and driving meaningful progress across the healthcare ecosystem. A Vision for the Future Reflecting on her time at Davos, Ms. Gong expressed her pride in representing China's AI-powered healthcare sector. "At Yidu Tech, our mission is to make precision healthcareaccessible to everyone b. We look forward to deepening our collaborations worldwide and contributing to the sustainable development of global healthcare." As Yidu Tech continues to expand its international presence, its commitment to collaboration and innovation ensures its role as a key partner in advancing healthcare for a healthier, more equitable world.
A12 藝術空間
AI in healthcare
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
